Author

D. A. Egorova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 2 Organism:bacteria (other)· 1 Research Focus:cell type annotation· 1 Organism:E. coli· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

A. I. Solovyev· 2 shared A. L. Gintsburg· 2 shared I. L. Tutykhina· 2 shared I. N. Kravtsov· 2 shared K. V. Danilova· 2 shared M. A. Dmitrieva· 2 shared N. B. Polyakov· 2 shared A. A. Derkaev· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

A. I. Solovyev

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Straightforward semi-quantitative MALDI-TOF MS based screening approach for selection of recombinant protein producing E. Coli

I. N. Kravtsov, A. I. Solovyev, E. A. Potemkina, A. V. Kartashova, M. A. Dmitrieva, K. V. Danilova, I. L. Tutykhina, N. B. Polyakov, D. A. Egorova

The paper introduces a MALDI-TOF MS-based method to screen recombinant protein-producing E. coli clones by assessing expression levels.

bioRxiv · Dec 31, 2023 · PreprintBioengineering

Biofilm matrix proteome of clinical strain of P. aeruginosa

D. A. Egorova, A. I. Solovyev, N. B. Polyakov, K. V. Danilova, A. A. Scherbakova, I. N. Kravtsov, M. A. Dmitrieva, V. S. Rykova, I. L. Tutykhina, Y. M. Romanova, A. L. Gintsburg

The paper reports the first biofilm matrix proteome of a clinical P. aeruginosa isolate, identifies enriched bioprocess groups, and discusses implications for antibiofilm therapeutics.

bioRxiv · Dec 21, 2021 · PreprintMicrobiology

Single-domain antibodies efficiently neutralize SARS-CoV-2 variants of concern, including Omicron variant

I. A. Favorskaya, D. V. Shcheblyakov, I. B. Esmagambetov, I. V. Dolzhikova, I. A. Alekseeva, A. I. Korobkova, D. V. Voronina, E. I. Ryabova, A. A. Derkaev, A. V. Kovyrshina, A. A. Iliukhina, A. G. Botikov, O. L. Voronina, D. A. Egorova, O. V. Zubkova, , A. L. Gintsburg

The paper identifies single-domain antibodies that neutralize SARS-CoV-2 variants, including Omicron, with enhanced potency through dimeric modifications.

bioRxiv · Nov 24, 2021 · PreprintImmunology